Waded Cruzado - 28 Feb 2025 Form 4 Insider Report for Goosehead Insurance, Inc. (GSHD)

Role
Director
Signature
/s/ John O'Connor, as Attorney-in-Fact for Waded Cruzado
Issuer symbol
GSHD
Transactions as of
28 Feb 2025
Net transactions value
-$1,002,151
Form type
4
Filing time
04 Mar 2025, 20:26:04 UTC
Previous filing
09 May 2024
Next filing
08 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GSHD Class A Common Stock Options Exercise $490,100 +8,450 +1314% $58.00 9,093 28 Feb 2025 Direct
transaction GSHD Class A Common Stock Sale $882,141 -7,448 -82% $118.44 1,645 28 Feb 2025 Direct F1
transaction GSHD Class A Common Stock Sale $120,010 -1,002 -61% $119.77 643 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GSHD Director Stock Options (right to buy) Options Exercise $490,100 -8,450 -57% $58.00 6,250 28 Feb 2025 Class A Common Stock 8,450 $58.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.10 to $118.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.29 to $120.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date, which was May 2, 2023; provided, that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan).